RARE
Ultragenyx
NASDAQ: RARE · HEALTHCARE · BIOTECHNOLOGY
$24.18
-1.43% today
Updated 2026-04-29
Market cap
$2.38B
P/E ratio
—
P/S ratio
3.53x
EPS (TTM)
$-5.83
Dividend yield
—
52W range
$18 – $42
Volume
2.0M
Ultragenyx (RARE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-11.5%
Last 4 quarters
Revenue YoY growth
+25.5%
Most recent quarter
EPS YoY growth
+7.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.5%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-14.1%
2026-02-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $-1.29 | -12.2% | $23.88 | $20.52 | -14.1% |
| 2025-11-06 | $-1.81 | -49.6% | $31.87 | $30.63 | -3.9% |
| 2025-08-05 | $-1.17 | +11.4% | $28.46 | $28.05 | -1.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.15 | $-1.29 | -12.2% | $207.00M | +25.5% |
| 2025-09-30 | $-1.21 | $-1.81 | -49.6% | $159.93M | +14.7% |
| 2025-06-30 | $-1.32 | $-1.17 | +11.4% | $166.50M | +13.2% |
| 2025-03-31 | $-1.64 | $-1.57 | +4.3% | $139.29M | +28.0% |
| 2024-12-31 | $-1.27 | $-1.39 | -9.4% | $164.88M | +29.4% |
| 2024-09-30 | $-1.47 | $-1.40 | +4.8% | $139.49M | +42.3% |
| 2024-06-30 | $-1.69 | $-1.52 | +10.1% | $147.03M | +35.7% |
| 2024-03-31 | $-1.73 | $-2.03 | -17.3% | $108.83M | — |
| 2023-12-31 | $-1.62 | $-1.52 | +6.2% | $127.39M | — |
| 2023-09-30 | $-2.08 | $-2.23 | -7.2% | $98.05M | — |
| 2023-06-30 | $-2.07 | $-2.25 | -8.7% | $108.31M | — |
Frequently asked questions
Has Ultragenyx beaten earnings estimates?
Ultragenyx has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -11.5% over the last 4 quarters.
How does RARE stock react to earnings?
RARE stock has moved an average of -6.5% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Ultragenyx's revenue growth rate?
Ultragenyx reported year-over-year revenue growth of +25.5% in its most recent quarter, with EPS growing +7.2% year-over-year.